Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6901124 | 1.00 | TDP1 (0.50) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL29843127 | 0.93 | TDP1 (0.49) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL29843210 | 0.91 | TDP1 (0.44) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL21959829 | 0.90 | TDP1 (0.58) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL7583624 | 0.88 | TDP1 (0.57) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL7583616 | 0.88 | TDP1 (0.57) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL7584156 | 0.88 | TDP1 (0.57) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL6898739 | 0.88 | TDP1 (0.48) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL6902771 | 0.88 | TDP1 (0.50) | TDP1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL13810599 | 0.87 | TDP1 (0.55) | TDP1MEN1KMT2ALMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7459168-B2 | Insecticide transpiration apparatus | DAINIHON JOCHUGIKU CO., LTD. (JP) | 2008-12-02 | — | — | US | claimed |
| EP-1352562-B1 | Insecticide transpiration apparatus | DAINIPPON JOCHUGIKU KK (JP) | 2006-11-15 | — | — | EP | claimed |
| US-6926902-B2 | Insecticide transpiration apparatus | DAINHON JOCHUGIKU CO., LTD. (JP) | 2005-08-09 | — | — | US | claimed |
| US-20040180070-A1 | Insecticide transpiration apparatus | DAINIHON JOCHUGIKU CO., LTD. (JP) | 2004-09-16 | — | — | US | claimed |
| EP-1352562-A1 | Insecticide transpiration apparatus | DAINIHON JOCHUGIKU CO., LTD. (JP) | 2003-10-15 | — | — | EP | claimed |
| US-20030160062-A1 | Insecticide transpiration apparatus | DAINIHON JOCHUGIKU CO., LTD. (JP) | 2003-08-28 | — | — | US | claimed |
| US-9238078-B2 | Modified-release pharmaceutical drug composition | COATING PLACE, INC. (US) | 2016-01-19 | — | — | US | disclosed |
| US-9125948-B2 | Ion exchange resin treated to control swelling | COATING PLACE, INC. (US) | 2015-09-08 | — | — | US | disclosed |
| US-8883213-B2 | Ion exchange resin treated to control swelling | COATING PLACE, INC. (US) | 2014-11-11 | — | — | US | disclosed |
| US-8343546-B2 | Ion exchange resin treated to control swelling | COATING PLACE, INC. (US) | 2013-01-01 | — | — | US | disclosed |
| US-8329224-B2 | Ion exchange resin treated to control swelling | COATING PLACE, INC. (US) | 2012-12-11 | — | — | US | disclosed |
| US-20120064167-A1 | MODIFIED-RELEASE PHARMACEUTICAL DRUG COMPOSITION | COATING PLACE, INC. (US) | 2012-03-15 | — | — | US | disclosed |
| EP-2413898-A1 | MODIFIED-RELEASE PHARMACEUTICAL DRUG COMPOSITION | Coating Place, Inc. (US) | 2012-02-08 | — | — | EP | disclosed |
| US-20070059270-A1 | Loading one or more drugs in a solution onto one or more ion exchange resin particles to form a drug-loaded resin particle which is separated from the solution and dried before recombining the drug-loaded resin particle with the solution to load more drugs onto the drug-load; controlled release | THE COATING PLACE, INC. (US) | 2007-03-15 | — | — | US | disclosed |
| EP-1352562-B1 | Insecticide transpiration apparatus | DAINIPPON JOCHUGIKU KK (JP) | 2006-11-15 | — | — | EP | disclosed |
| US-6926902-B2 | Insecticide transpiration apparatus | DAINHON JOCHUGIKU CO., LTD. (JP) | 2005-08-09 | — | — | US | disclosed |
| US-20040180070-A1 | Insecticide transpiration apparatus | DAINIHON JOCHUGIKU CO., LTD. (JP) | 2004-09-16 | — | — | US | disclosed |
| EP-1439163-A1 | PROPARGYLBENZYL ALCOHOL ESTER DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND INSECTICIDE/INSECTIFUGE CONTAINING THE SAME | DAINIHON JOCHUGIKU CO., LTD. (JP) | 2004-07-21 | — | — | EP | disclosed |
| EP-1352562-A1 | Insecticide transpiration apparatus | DAINIHON JOCHUGIKU CO., LTD. (JP) | 2003-10-15 | — | — | EP | disclosed |
| US-20030160062-A1 | Insecticide transpiration apparatus | DAINIHON JOCHUGIKU CO., LTD. (JP) | 2003-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040180070-A1 | Insecticide transpiration apparatus | TIMM13, PIK3C3, ATP5PD | TDP1 2733/4885MEN1 4117/4885KMT2A 3655/4885 |
| US-20030160062-A1 | Insecticide transpiration apparatus | PIK3C3, ACHE, ATP5PD | TDP1 1190/4885MEN1 4401/4885KMT2A 4329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.